Admitted local publications that cite Reconciling Conflicting Evidence on Peri–Immune Checkpoint Inhibitor COVID-19 mRNA Vaccination in Lung Cancer: A Time-Aligned Target Trial Emulation–Informed Landmark Study.
No admitted local citation edges point to this work yet.
Cited by — Reconciling Conflicting Evidence on Peri–Immune Checkpoint Inhibitor COVID-19 mRNA Vaccination in Lung Cancer: A Time-Aligned Target Trial Emulation–Informed Landmark Study | ResearchHub - ResearchHub
